Open Procurement Albania

Loti 38 Atorvastatine

Contracted Institution Ministry of Health
Tenderer Institution Ministry of Health
Tender object B2- Blerje barna Gjaku dhe organet formuese të gjakut, Lënde kontrasti për CT, Lëndë Kontrasti gastrointestinale, Lëndë kontrasti për MRI, Metabolizmi dhe trakti tretës, Organet e shqisave, Psikiatrik, Sistemi kardiovaskular, Sistemi muskolo-skeletik dhe Sistemi nervor

Loti 38 Atorvastatine

Burimi i Financimit: Buxheti i shtetit.
Reference No. REF-49128-02-05-2020
Estimated / Ceiling Value ALL without VAT 2 509 727,00
Type of Contract
Procurement Method Open Procedure above the high monetary limit
Stage Procedure Announced the Winner
Tender Publication Date 06-02-2020
Last date of Submitted Documents 10-04-2020
Tender Held Date 10-04-2020
No. of Bidders 2
Bidders Aldosch-Farma SHPK
Trimed
Successful Bidder /Supplier / Provider
  • Aldosch-Farma SHPK
  • The winning bid ALL without vat 2.99 leke per njesi.
    Bidder Announcement date 10-06-2020
    Award and Contract Amount ALL with VAT
    Contract date
    Planned Milestones of Contract / Start and End Date Kontratat mund te lidhen nga AK perfituese brenda afatit 24 muaj nga data e neshkrimit te MK nga palet, për secilin lot.
    Renewal Contract Additional Value (ALL with VAT)
    Appeals Nuk ka pasur ankesa dhe skualifikime.
    Cancellation reason
    Additions
    Transaction / Actual Spending
  • Monitor treasury transaction for Aldosch-Farma SHPK viti 2012-2013
    Monitor treasury transaction for Aldosch-Farma SHPK viti 2014
    Monitor treasury transaction for Aldosch-Farma SHPK viti 2015-2018
    Monitor treasury transaction for Aldosch-Farma SHPK viti 2019-2020
  • Public Announcement Bulletin Contracts signed under the Framework Agreement Ministria e Shëndetësisë REF-49128-02-05-2020
    Announcement of Procurement Nr. 5 datë 10 Shkurt 2020
    Standard Tender Documents
    Bidder Announcement
    Signing of the Contract
    Modifikim ne DST (I)


    Modifikim në DST (II)

    Contact Notification - Financial Times